secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2022-03-09T23:59:59+00:00
Accession:  0000950170-22-003221
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta Pharmaceuticals amends equity plan, adds 1.05M shares for issuance
-------------------------------------------------------------------------

- Stockholders approved amendment to 2019 Equity Incentive Plan at March 3, 2022 annual meeting.
- Increase of 1,050,000 shares of common stock reserved for issuance under the plan.
- Plan as amended filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/0000950170-22-003221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/enta-20220303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-003221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer